PARENTERAL NUTRITION MARKET IS ANTICIPATED TO WITNESS HIGH GROWTH OWING TO RISING PREVALENCE OF CHRONIC DISEASES

Parenteral Nutrition Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases

Parenteral Nutrition Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Chronic Diseases

Blog Article

The parenteral nutrition market encompasses a range of intravenous feeding solutions and products designed to provide essential nutrients to patients who are unable to consume or absorb adequate nutrition through oral or enteral routes. These specialized formulations contain a balanced mix of macronutrients, micronutrients, and fluids tailored to meet the specific nutritional needs of critically ill or malnourished individuals. Parenteral nutrition plays a vital role in supporting patient recovery, maintaining body functions, and preventing nutrient deficiencies in various healthcare settings, including hospitals, long-term care facilities, and home healthcare.


According to coherent market insights the global parenteral nutrition market was valued US$ 4,548.7 Mn in 2025 and is expected to reach US$ 6,939 Mn by 2032 growing at a compound annual growth rate (CAGR) of 6.20% from 2025 to 2032.

Key Takeaways

Key players operating in the  Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Grifols, S.A., copyright, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., Vifor Pharma Management Ltd., Allergan plc, Aculife Healthcare Private Ltd., Grifols, S.A., Ori Bionature (Malaysia) Sdn. Bhd., Servona GmbH, and CHEPLAPHARM Arzneimittel GmbH. These companies are focusing on strategies such as mergers, acquisitions, partnerships, and product launches to strengthen their market presence and expand their product portfolios to cater to the growing demand for parenteral nutrition solutions.

The Parenteral Nutrition Market Demand presents significant growth opportunities driven by the increasing prevalence of chronic diseases, rising number of premature births, and growing awareness about the importance of proper nutrition in critically ill patients. Additionally, the development of innovative formulations, such as ready-to-use and customized parenteral nutrition solutions, is expected to fuel market growth. The adoption of parenteral nutrition in home healthcare settings and the growing demand for single-dose amino acid solutions also offer lucrative opportunities for market players.

The parenteral nutrition market is witnessing global expansion, with increasing demand across various regions. North America dominates the market, owing to the high prevalence of chronic diseases, well-established healthcare infrastructure, and favorable reimbursement policies. Europe is also a significant market, driven by the rising geriatric population and increasing healthcare expenditure. The Asia-Pacific region is expected to exhibit the highest growth rate, attributed to the improving healthcare infrastructure, rising healthcare awareness, and growing investments by key players to tap into the untapped market potential in emerging economies such as China and India.

Market Drivers:
The rising prevalence of chronic diseases, such as cancer, diabetes, and gastrointestinal disorders, is a major driver for the parenteral nutrition market. Patients with these conditions often require parenteral nutrition support due to their inability to absorb nutrients through normal dietary intake. As the burden of chronic diseases continues to increase worldwide, the demand for parenteral nutrition solutions is expected to rise, driving market growth.

Market Restraint:
The high cost associated with parenteral nutrition therapy is a significant restraint for the market. Parenteral nutrition solutions, especially customized formulations, are expensive compared to enteral nutrition products. Additionally, the need for specialized equipment, skilled healthcare professionals, and stringent manufacturing processes further contributes to the high cost of parenteral nutrition. The high cost may limit the adoption of parenteral nutrition in certain regions and among cost-sensitive healthcare facilities, thereby restraining market growth.



Segment Analysis

The Parenteral Nutrition Market can be segmented based on nutrition type, consumer age group, and end-user. In terms of nutrition type, the market is divided into carbohydrates, lipid emulsion, single dose amino acid solution, trace elements, and vitamins. The lipid emulsion segment is expected to hold a significant share of the market due to its ability to provide essential fatty acids and energy to patients who cannot consume food orally. The single dose amino acid solution segment is also expected to witness substantial growth, as it helps in protein synthesis and tissue repair.

Based on consumer age group, the market is segmented into children and newborns, adults, and geriatrics. The adults segment is anticipated to dominate the market, as this age group is more susceptible to chronic diseases and disorders that require parenteral nutrition. The geriatric segment is expected to experience the fastest growth due to the increasing aging population and the prevalence of age-related ailments.

Global Analysis

Geographically, the Parenteral Nutrition Market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market throughout the forecast period, owing to the high prevalence of chronic diseases, well-established healthcare infrastructure, and increasing healthcare expenditure in the region. The United States is the major contributor to the North American market, driven by the growing demand for parenteral nutrition in home care settings and the rising incidence of cancer and gastrointestinal disorders.

Europe is anticipated to hold a significant share of the global market, with countries such as Germany, France, and the United Kingdom being the key contributors. The market growth in this region is attributed to the increasing prevalence of chronic disorders, the growing geriatric population, and the rising demand for home healthcare services.

The Asia-Pacific region is expected to witness the fastest growth in the Parenteral Nutrition Market during the forecast period. This growth is driven by factors such as the increasing prevalence of chronic diseases, improving healthcare infrastructure, and rising healthcare expenditure in countries like China, India, and Japan. Additionally, the growing awareness about the benefits of parenteral nutrition and the increasing number of premature births in the region are expected to fuel market growth.



Get More Insights On- Parenteral Nutrition Market


 


Get This Report In Japanese Language-


 


  非経口栄養市場




Get This Report In Korean Language -



  비경구 영양 시장



Read More Blog Related to this Industry-  Bloom Nutrition Set to Revolutionize Soda Industry with New Launch of Bloom Pop



About Author:



Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.



( LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137  )


 



copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript">

Report this page